Category: St. Jude MedicalSyndicate content

Abbott to expand medical device footprint? | Medtech Wall Street news for the week of May 12, 2014

May 15, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott may look to expand medical device business footprint; Device makers take big writedowns on renal denervation; Cardinal Health closes $320M AccessClosure buy; K2M prices IPO under range at $132M; Allergan board spurns Valeant's $47B offer.

Abbott may look to expand medical device business footprint

May 9, 2014 by Brad Perriello

Abbott may look to expand medical device business footprint

TAVI: St. Jude implants 1st patients in U.S. Portico study

May 14, 2014 by Arezu Sarvestani

St. Jude Medical launches a U.S. study of its Portico transcatheter aortic valve in patients who are not candidates for open heart surgery.

St. Jude implants 1st patient in U.S. Portico study

Minnesota medtech maker St. Jude Medical (NYSE:STJ) launched a U.S. study of its Portico catheter-based aortic valve, enrolling the 1st patients in pursuit of FDA approval for the implant.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Device makers take big writedowns on renal denervation

May 13, 2014 by Brad Perriello

Boston Scientific, Medtronic and Covidien take millions in write-downs on their renal denervation assets after the failure of Medtronic's Symplicity-3 trial.

Device makers take big writedowns on renal denervation

HRS2014: Perforations, deaths temporarily derail St. Jude's E.U. Nanostim study

May 12, 2014 by Arezu Sarvestani

Two perforation-related deaths and 4 additional adverse events temporarily derail enrollment in St. Jude Medical's European Nanostim registry as the company evaluates the patient injuries.

Updated May 12, 2014, at 5:30 p.m. with confirmation from St. Jude Medical.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HRS2014 wrap-up: Medtronic delays ICD therapy, Boston Scientific watches patients from afar, and more

May 12, 2014 by Arezu Sarvestani

Medtech's biggest players release a slew of new reports at this year's Heart Rhythm Society conference, with Medtronic data on preventive shocks for ICD patients, lowered mortality for patients remotely monitored with Boston Scientific's LATITUDE system, and more.

HRS2014 wrap-up: Medtronic delays ICD therapy, Boston Scientific watches patients from afar, and more

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HRS2014: St. Jude Medical and the ghost of product recall past

May 12, 2014 by Arezu Sarvestani

Researchers at this year's Heart Rhythm Society conference are still struggling to figure out the best way to manage patients still implanted with St. Jude Medical's recalled Riata defibrillator leads, but the company won some hearts with strong findings for its next-generation Optim-coated devices.

HRS2014: St. Jude and the ghost of product recall past

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DOJ probes St. Jude | Medtech legal news for the week of May 12, 2014

May 12, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Justice Dept. probes St. Jude for potential False Claims, kickbacks violations; More secret human studies uncovered in Myxo ring inquiry; Medtech manufacturer fleeced Stryker, says former exec; FDA morcellator warning spurs lawsuit against J&J; NuVasive claims win in patent spat with Cadwell Labs

Justice Dept. probes St. Jude for potential False Claims, kickbacks violations

May 6, 2014 by Arezu Sarvestani

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp